Page last updated: 2024-09-04

beta-lactams and Infective Endocarditis

beta-lactams has been researched along with Infective Endocarditis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's4 (57.14)2.80

Authors

AuthorsStudies
Everson, N; Freeman, L; McDaniel, L; Milkovits, A1
Albert, R; Caillault, L; Dorel, M; Lalanne, S; Le Bot, A; Lemaignen, A; Revest, M; Tattevin, P; Verdier, MC1
Aouba, A; Auzou, M; Creveuil, C; de La Blanchardière, A; Franconieri, F; Join-Lambert, O; Labombarda, F; Verdon, R1
Achermann, Y; Benussi, S; Boumasmoud, M; Dengler Haunreiter, V; Häffner, N; Kühnert, D; Leimer, N; Rachmühl, C; Vulin, C; Wipfli, D; Zbinden, R; Zinkernagel, AS1
Fisher, MA; Spivak, ES; Timbrook, TT; Tritle, BJ1
D'Agostino, C; Rhodes, NJ; Roberts, JA; Scheetz, MH; Skoglund, E1
Carbon, C; Farinotti, R; Goldstein, F; Gutmann, L; Mainardi, JL; Mohler, J; Zhou, XY1

Reviews

1 review(s) available for beta-lactams and Infective Endocarditis

ArticleYear
Rothia spp. infective endocarditis: A systematic literature review.
    Infectious diseases now, 2021, Volume: 51, Issue:3

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Cardiac Surgical Procedures; Child; Echocardiography; Endocarditis; Endocarditis, Bacterial; Female; Humans; Male; Micrococcaceae; Middle Aged; Treatment Outcome; Young Adult

2021

Other Studies

6 other study(ies) available for beta-lactams and Infective Endocarditis

ArticleYear
Evaluation of penicillin-gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis.
    International journal of antimicrobial agents, 2022, Volume: 59, Issue:3

    Topics: Adult; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Endocarditis; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Penicillins; Retrospective Studies

2022
Amoxicillin therapeutic drug monitoring for endocarditis: A comparative study (EI-STAB).
    International journal of antimicrobial agents, 2023, Volume: 62, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Drug Monitoring; Endocarditis; Endocarditis, Bacterial; Enterococcus; Humans; Male; Middle Aged; Retrospective Studies; Streptococcus

2023
In-host evolution of Staphylococcus epidermidis in a pacemaker-associated endocarditis resulting in increased antibiotic tolerance.
    Nature communications, 2019, 03-08, Volume: 10, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactams; Biofilms; Drug Resistance, Multiple; Drug Tolerance; Endocarditis; Evolution, Molecular; Fluoroquinolones; Glycopeptides; Host-Pathogen Interactions; Humans; INDEL Mutation; Male; Microbial Sensitivity Tests; Pacemaker, Artificial; Peptides, Cyclic; Phylogeny; Polymorphism, Single Nucleotide; Staphylococcal Infections; Staphylococcus epidermidis

2019
Penicillin as a Potential Agent for Dual β-Lactam Therapy for Enterococcal Endocarditis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 03-03, Volume: 70, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactams; Endocarditis; Endocarditis, Bacterial; Enterococcus faecalis; Humans; Penicillins; Sepsis

2020
Microbiologic clearance following transition from standard infusion piperacillin-tazobactam to extended-infusion for persistent Gram-negative bacteremia and possible endocarditis: A case report and review of the literature.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:10

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Endocarditis; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2015
Activity of isepamicin and selection of permeability mutants to beta-lactams during aminoglycoside therapy of experimental endocarditis due to Klebsiella pneumoniae CF104 producing an aminoglycoside acetyltransferase 6' modifying enzyme and a TEM-3 beta-l
    The Journal of infectious diseases, 1994, Volume: 169, Issue:6

    Topics: Acetyltransferases; Amikacin; Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Cell Membrane Permeability; Disease Models, Animal; Drug Therapy, Combination; Endocarditis; Female; Gentamicins; Klebsiella pneumoniae; Mutation; Rabbits

1994